Pricing:

Single User Licence
$4200
Multi User License Upto 5 Users
$6500
Enterprise License
$8400
Download Sample Add to Cart Buy Now

Don’t see what you are Looking For:

We can create a custom report for you, please fill the form below

Global Cardiac Rhythm Management (CRM) Devices And Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Pacemakers (Implantable Pacemakers and External Pacemakers), Defibrillators (Implantable Cardioverter Defibrillators and External Defibrillator), and Cardiac Resynchronization Therapy (CRT)

By Application;

Bradycardia, Tachycardia, Heart Failure, and Others

By End User;

Hospitals, Ambulatory Surgical Centers, and Physicians Clinics

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)

Report ID: Rn819265911 Published Date: May, 2025 Updated Date: June, 2025

Download Free Sample Now Request Customized Sample

Cardiac Rhythm Management (CRM) Devices And Equipment Market Overview

Cardiac Rhythm Management (CRM) Devices And Equipment Market (USD Million)

Cardiac Rhythm Management (CRM) Devices And Equipment Market was valued at USD 17,156.45 million in the year 2024. The size of this market is expected to increase to USD 25,933.56 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.1%.

Global Cardiac Rhythm Management (CRM) Devices And Equipment Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 6.1 %

Study Period	2025 - 2031
Base Year	2024
CAGR (%)	6.1 %
Market Size (2024)	USD 17,156.45 Million
Market Size (2031)	USD 25,933.56 Million
Market Concentration	Medium
Report Pages	339

17,156.45

2024

25,933.56

2031

Major Players

Medtronic
Abbott Laboratories
Boston Scientific Corporation
Biotronik
MicroPort Scientific Corporation

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Cardiac Rhythm Management (CRM) Devices And Equipment Market

Fragmented - Highly competitive market without dominant players

The cardiac rhythm management (CRM) devices and equipment market is steadily expanding due to the rising incidence of cardiac arrhythmias, including atrial fibrillation and bradycardia. These rhythm disorders now affect over 30% of cardiovascular patients, driving the need for effective, technology-driven interventions that improve long-term cardiac outcomes and reduce hospitalization rates.

Advancements in CRM Technology
Technological innovation is a central growth driver in the CRM space. Modern devices now offer wireless connectivity, remote monitoring, and miniaturized designs, significantly enhancing patient comfort and device efficacy. Around 40% of recently launched CRM solutions emphasize these features, highlighting a shift toward intelligent and patient-friendly systems.

Surging Use of Implantable Devices
Implantable CRM devices, such as pacemakers and defibrillators, have become the preferred choice in managing rhythm disorders. Over 60% of CRM interventions now utilize implantable technologies due to their high reliability and clinical success in preventing sudden cardiac arrest. Growing awareness among patients and clinicians has further boosted adoption rates.

Remote Monitoring and Telehealth Integration
A growing number of CRM devices now support real-time remote monitoring, a feature integrated into more than 45% of systems currently in use. This connectivity allows clinicians to track patient data continuously, enabling timely interventions and reducing emergency room visits—making CRM technology a critical component of proactive cardiac care.

Favorable Regulatory and Clinical Adoption
The market is also benefiting from a supportive regulatory environment and inclusion of CRM devices in chronic care programs. With over 35% of healthcare providers incorporating these tools into their care models, CRM technologies are becoming standard in cardiac treatment plans. Positive reimbursement structures and growing clinical trust are further reinforcing market growth.

Cardiac Rhythm Management (CRM) Devices And Equipment Market Recent Developments

In March 2025, Abbott reported favorable clinical outcomes from its trial of the AVEIR DR dual-chamber leadless pacemaker system. These results highlight the system’s effectiveness and reinforce its potential as a next-generation solution in cardiac rhythm management (CRM), offering a less invasive and more advanced option for patients requiring dual-chamber pacing.
In January 2025, Medtronic secured expanded FDA approval for its Micra AV2 and VR2 leadless pacemakers. This regulatory milestone allows for broader use in patients with bradyarrhythmia, enhancing access to advanced pacing technology designed to deliver effective, minimally invasive cardiac therapy.

Cardiac Rhythm Management (CRM) Devices And Equipment Market Segment Analysis

In this report, the Cardiac Rhythm Management (CRM) Devices and Equipment Market has been segmented by Product, Application, End User, and Geography.

Cardiac Rhythm Management (CRM) Devices And Equipment Market, Segmentation by Product

The Cardiac Rhythm Management (CRM) Devices And Equipment Market has been segmented by Product into Pacemakers, Defibrillators and Cardiac Resynchronization Therapy (CRT).

Pacemakers

Pacemakers represent roughly 30% of the CRM market. These devices help regulate slow heart rhythms caused by electrical conduction disorders, ensuring a consistent heartbeat and preventing symptoms like fatigue and dizziness.

Defibrillators

Defibrillators account for approximately 45% of the market. These life-saving devices deliver high-energy shocks to restore normal rhythm during sudden cardiac events, significantly reducing mortality rates from arrhythmias.

Cardiac Resynchronization Therapy (CRT)

CRT devices make up about 25% of the market. They are designed to synchronize ventricular contractions in patients with heart failure, improving cardiac output, reducing hospitalizations, and enhancing quality of life.

Cardiac Rhythm Management (CRM) Devices And Equipment Market, Segmentation by Application

The Cardiac Rhythm Management (CRM) Devices And Equipment Market has been segmented by Application into Bradycardia, Tachycardia, Heart Failure, and Others.

Bradycardia

Bradycardia accounts for about 35% of the CRM market. Pacemakers are widely used to manage slow heart rhythms, ensuring adequate cardiac output and reducing the risk of complications.

Tachycardia

Tachycardia makes up nearly 30% of the market. Defibrillators and anti-tachycardia pacing devices play a crucial role in controlling rapid, irregular heartbeats, preventing life-threatening arrhythmias.

Heart Failure

Heart failure contributes approximately 25% of the market. Cardiac resynchronization therapy (CRT) devices help improve heart function and quality of life by synchronizing ventricular contractions in heart failure patients.

Others

The “Others” segment holds around 10% of the market. This includes devices used for managing rare arrhythmias and cardiac conditions that require rhythm control, expanding the therapeutic reach of CRM technologies.

Cardiac Rhythm Management (CRM) Devices And Equipment Market, Segmentation by End User

The Cardiac Rhythm Management (CRM) Devices And Equipment Market has been segmented by End User into Hospitals, Ambulatory Surgical Centers, and Physicians Clinics

Hospitals
Hospitals lead the cardiac rhythm management (CRM) devices market with over 55% share, thanks to their capacity to perform complex cardiac procedures and manage emergencies effectively. Equipped with advanced medical infrastructure and skilled healthcare professionals, hospitals remain the primary choice for patients requiring CRM solutions.

Ambulatory Surgical Centers
Accounting for nearly 25% of the CRM market, Ambulatory Surgical Centers (ASCs) provide a cost-effective alternative to traditional hospitals. Their efficiency in handling outpatient cardiac procedures, combined with shorter recovery times, makes them a preferred option for selected CRM interventions.

Physicians Clinics
With about 20% market share, physicians clinics play a crucial role in delivering outpatient CRM services. These clinics focus on device monitoring, routine diagnostics, and follow-ups, supporting long-term cardiac rhythm management in non-hospital settings.

Cardiac Rhythm Management (CRM) Devices And Equipment Market, Segmentation by Geography

In this report, the Cardiac Rhythm Management (CRM) Devices And Equipment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Regions and Countries Analyzed in this Report

Legend

North America

Rest of North America

Europe

Rest of Europe

Asia Pacific

Rest of Asia Pacific

Middle East and Africa

Rest of Middle East and Africa

Latin America

Rest of Latin America

Rest of the World

Cardiac Rhythm Management (CRM) Devices And Equipment Market Share (%), by Geographical Region

North America

North America captures about 40% of the CRM market. Advanced healthcare infrastructure, high awareness levels, and widespread adoption of CRM technologies position this region at the forefront.

Europe

Europe holds nearly 30% of the market. The region benefits from a strong focus on cardiac care, robust healthcare systems, and the rising use of innovative CRM devices.

Asia Pacific

Asia Pacific represents around 20% of the market. Rapid advancements in healthcare facilities, increasing awareness of cardiac health, and rising incidence of heart diseases drive growth in this region.

Middle East and Africa

Middle East and Africa contribute about 5% of the market. The region is experiencing steady growth thanks to improving healthcare systems and increased investments in cardiac care services.

Latin America

Latin America makes up nearly 5% of the market. Expanding healthcare infrastructure and increasing awareness of cardiac conditions are contributing to steady market growth in this region.

Cardiac Rhythm Management (CRM) Devices And Equipment Market Trends

This report provides an in depth analysis of various factors that impact the dynamics of Cardiac Rhythm Management (CRM) Devices And Equipment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.

Comprehensive Market Impact Matrix

This matrix outlines how core market forces—Drivers, Restraints, and Opportunities—affect key business dimensions including Growth, Competition, Customer Behavior, Regulation, and Innovation.

Market Forces ↓ / Impact Areas →	Market Growth Rate	Competitive Landscape	Customer Behavior	Regulatory Influence	Innovation Potential
Drivers	High impact (e.g., tech adoption, rising demand)	Encourages new entrants and fosters expansion	Increases usage and enhances demand elasticity	Often aligns with progressive policy trends	Fuels R&D initiatives and product development
Restraints	Slows growth (e.g., high costs, supply chain issues)	Raises entry barriers and may drive market consolidation	Deters consumption due to friction or low awareness	Introduces compliance hurdles and regulatory risks	Limits innovation appetite and risk tolerance
Opportunities	Unlocks new segments or untapped geographies	Creates white space for innovation and M&A	Opens new use cases and shifts consumer preferences	Policy shifts may offer strategic advantages	Sparks disruptive innovation and strategic alliances

Drivers, Restraints and Opportunity Analysis

Drivers

Rising cardiovascular diseases
Growing healthcare expenditure
Increasing awareness campaigns - Rising awareness campaigns centered on cardiac health and arrhythmia prevention are playing a vital role in driving the growth of the cardiac rhythm management (CRM) devices and equipment market. Initiatives led by healthcare organizations, non-profits, and government agencies are increasing public understanding of heart rhythm disorders, early warning signs, and treatment options. As a result, more individuals are undergoing routine heart screenings and seeking timely care, leading to a higher demand for advanced CRM solutions such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.

These campaigns are not only improving health literacy but also helping to reduce stigma and misinformation surrounding the use of implantable cardiac devices. Through targeted education and outreach, patients and clinicians alike are becoming more confident in the clinical value of CRM technologies. As awareness continues to grow, particularly in regions where access to cardiac care had previously been limited, the adoption of rhythm management devices is expected to rise steadily, supporting long-term global market expansion.

Restraints

Stringent regulatory policies
Limited healthcare access
Skilled personnel shortage
Reimbursement challenges globally - Global reimbursement disparities remain a major challenge for the cardiac rhythm management (CRM) devices and equipment market. While devices such as pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) systems are clinically proven to improve patient outcomes, access to these technologies is often limited by inadequate or inconsistent reimbursement policies. In many countries, patients are faced with high out-of-pocket costs or delayed approvals, which can deter timely treatment and reduce overall adoption rates.

Even in regions with established healthcare systems, evolving reimbursement structures and efforts to control spending can restrict the integration of next-generation CRM technologies. Hospitals and clinics may hesitate to invest in advanced equipment without assurance of adequate financial return or insurance coverage. This ongoing issue limits innovation uptake and slows market growth, highlighting the need for more transparent, streamlined, and equitable reimbursement frameworks to expand global access to life-saving CRM solutions.

Opportunities

Innovative product development
Personalized medicine trends
Strategic collaborations expanding - Strategic collaborations among medical device manufacturers, hospitals, research institutions, and digital health companies are creating significant opportunities in the cardiac rhythm management (CRM) devices and equipment market. These partnerships are helping to accelerate product development, improve clinical validation, and enhance global market penetration. By pooling resources and expertise, stakeholders can drive innovation in CRM technologies and streamline the integration of advanced features such as remote monitoring, AI-based diagnostics, and personalized therapy adjustments.

Collaborative efforts are particularly impactful in expanding access to CRM devices in emerging markets. Joint ventures and partnerships with local distributors or health systems can overcome regulatory, logistical, and pricing barriers. Such collaborations facilitate more efficient deployment of life-saving technologies like implantable cardioverter defibrillators (ICDs), pacemakers, and CRT devices, while also supporting physician training and awareness campaigns that increase acceptance and adoption.

Partnerships between device companies and telehealth providers are transforming the way post-implantation care is delivered. By integrating CRM devices with digital platforms, patients can be continuously monitored from home, improving treatment outcomes and reducing hospital readmissions. These advancements are also helping providers manage larger patient volumes with greater efficiency, aligning with healthcare systems’ broader shift toward value-based and decentralized care models.

As strategic collaborations continue to grow in scope and scale, they are expected to significantly influence the future of cardiac rhythm management. These alliances will not only foster technological advancement but also help bridge gaps in care delivery and affordability, positioning CRM devices as a central component of next-generation cardiac care worldwide.

Cardiac Rhythm Management (CRM) Devices And Equipment Market Competitive Landscape Analysis

Key players in Cardiac Rhythm Management (CRM) Devices And Equipment Market include :

Medtronic plc
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK SE & Co. KG
Koninklijke Philips N.V.
MicroPort Scientific Corporation
ZOLL Medical Corporation (Asahi Kasei Corporation)
Physio-Control, Inc. (Stryker)
LivaNova PLC
Schiller AG

In this report, the profile of each market player provides following information:

Company Overview and Product Portfolio
Market Share Analysis
Key Developments
Financial Overview
Strategies
Company SWOT Analysis

Introduction
1. Research Objectives and Assumptions
2. Research Methodology
3. Abbreviations
Market Definition & Study Scope
Executive Summary
1. Market Snapshot, By Product
2. Market Snapshot, By Application
3. Market Snapshot, By End User
4. Market Snapshot, By Region
Cardiac Rhythm Management (CRM) Devices And Equipment Market Dynamics
1. Drivers, Restraints and Opportunities
  1. Drivers
    1. Rising cardiovascular diseases
    2. Growing healthcare expenditure
    3. Increasing awareness campaigns
  2. Restraints
    1. Stringent regulatory policies
    2. Limited healthcare access
    3. Skilled personnel shortage
    4. Reimbursement challenges globally
  3. Opportunities
    1. Innovative product development
    2. Personalized medicine trends
    3. Strategic collaborations expanding
2. PEST Analysis
  1. Political Analysis
  2. Economic Analysis
  3. Social Analysis
  4. Technological Analysis
3. Porter's Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of Substitutes
  4. Threat of New Entrants
  5. Competitive Rivalry
Market Segmentation
1. Cardiac Rhythm Management (CRM) Devices And Equipment Market, By Product, 2021 - 2031 (USD Million)
  1. Pacemakers
    1. Implantable Pacemakers
    2. External Pacemakers
  2. Defibrillators
    1. Implantable Cardioverter Defibrillators
    2. External Defibrillator
  3. Cardiac Resynchronization Therapy (CRT)
2. Cardiac Rhythm Management (CRM) Devices And Equipment Market, By Application, 2021 - 2031 (USD Million)
  1. Bradycardia
  2. Tachycardia
  3. Heart Failure
  4. Others
3. Cardiac Rhythm Management (CRM) Devices And Equipment Market, By End User, 2021 - 2031 (USD Million)
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Physicians Clinics
4. Cardiac Rhythm Management (CRM) Devices And Equipment Market, By Geography, 2021 - 2031 (USD Million)
  1. North America
    1. United States
    2. Canada
  2. Europe
    1. Germany
    2. United Kingdom
    3. France
    4. Italy
    5. Spain
    6. Nordic
    7. Benelux
    8. Rest of Europe
  3. Asia Pacific
    1. Japan
    2. China
    3. India
    4. Australia & New Zealand
    5. South Korea
    6. ASEAN (Association of South East Asian Countries)
    7. Rest of Asia Pacific
  4. Middle East & Africa
    1. GCC
    2. Israel
    3. South Africa
    4. Rest of Middle East & Africa
  5. Latin America
    1. Brazil
    2. Mexico
    3. Argentina
    4. Rest of Latin America
Competitive Landscape
1. Company Profiles
  1. Medtronic plc
  2. Abbott Laboratories
  3. Boston Scientific Corporation
  4. BIOTRONIK SE & Co. KG
  5. Koninklijke Philips N.V.
  6. MicroPort Scientific Corporation
  7. ZOLL Medical Corporation (Asahi Kasei Corporation)
  8. Physio-Control, Inc. (Stryker)
  9. LivaNova PLC
  10. Schiller AG
Analyst Views
Future Outlook of the Market